SomnoMed Past Earnings Performance
Past criteria checks 0/6
SomnoMed's earnings have been declining at an average annual rate of -68.9%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 9.4% per year.
Key information
-68.9%
Earnings growth rate
-68.7%
EPS growth rate
| Medical Equipment Industry Growth | 5.8% |
| Revenue growth rate | 9.4% |
| Return on equity | -35.1% |
| Net Margin | -11.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
SomnoMed Limited (ASX:SOM) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Apr 15
SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?
Mar 04Market Still Lacking Some Conviction On SomnoMed Limited (ASX:SOM)
Dec 21SomnoMed Limited (ASX:SOM) Could Be Riskier Than It Looks
Sep 02Is SomnoMed (ASX:SOM) Using Too Much Debt?
Jun 19It's Unlikely That SomnoMed Limited's (ASX:SOM) CEO Will See A Huge Pay Rise This Year
Nov 18SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?
Sep 27Is SomnoMed (ASX:SOM) Using Debt Sensibly?
May 10Is SomnoMed (ASX:SOM) Using Debt Sensibly?
Oct 26Health Check: How Prudently Does SomnoMed (ASX:SOM) Use Debt?
May 12Could The SomnoMed Limited (ASX:SOM) Ownership Structure Tell Us Something Useful?
Mar 02Have Insiders Been Buying SomnoMed Limited (ASX:SOM) Shares?
Feb 01
Is SomnoMed (ASX:SOM) Using Debt In A Risky Way?
Dec 28Is SomnoMed Limited (ASX:SOM) Trading At A 38% Discount?
Dec 01Analysts Just Published A Bright New Outlook For SomnoMed Limited's (ASX:SOM)
Jul 28SomnoMed Limited (ASX:SOM) Insiders Increased Their Holdings
Jul 14Revenue & Expenses BreakdownBeta
How SomnoMed makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 89 | -11 | 56 | 0 |
| 30 Sep 23 | 86 | -9 | 53 | 0 |
| 30 Jun 23 | 84 | -8 | 51 | 0 |
| 31 Mar 23 | 81 | -7 | 49 | 0 |
| 31 Dec 22 | 79 | -5 | 48 | 0 |
| 30 Sep 22 | 76 | -5 | 46 | 0 |
| 30 Jun 22 | 73 | -4 | 44 | 0 |
| 31 Mar 22 | 69 | -5 | 43 | 0 |
| 31 Dec 21 | 66 | -5 | 41 | 0 |
| 30 Sep 21 | 64 | -3 | 38 | 0 |
| 30 Jun 21 | 63 | -1 | 35 | 0 |
| 31 Mar 21 | 59 | -1 | 32 | 0 |
| 31 Dec 20 | 55 | -1 | 30 | 0 |
| 30 Sep 20 | 56 | -1 | 30 | 0 |
| 30 Jun 20 | 57 | 0 | 31 | 0 |
| 31 Mar 20 | 60 | 0 | 32 | 0 |
| 31 Dec 19 | 63 | 1 | 33 | 0 |
| 30 Sep 19 | 61 | 0 | 32 | 0 |
| 30 Jun 19 | 59 | 0 | 32 | 0 |
| 31 Mar 19 | 58 | 2 | 32 | 0 |
| 31 Dec 18 | 56 | 3 | 31 | 0 |
| 30 Sep 18 | 54 | 3 | 30 | 0 |
| 30 Jun 18 | 52 | 2 | 29 | 0 |
| 31 Mar 18 | 51 | -1 | 30 | 0 |
| 31 Dec 17 | 50 | -4 | 32 | 0 |
| 30 Sep 17 | 50 | -4 | 32 | 0 |
| 30 Jun 17 | 49 | -3 | 31 | 0 |
| 31 Mar 17 | 48 | -2 | 29 | 0 |
| 31 Dec 16 | 47 | -1 | 26 | 0 |
| 30 Sep 16 | 45 | 0 | 25 | 0 |
| 30 Jun 16 | 44 | 0 | 24 | 0 |
| 31 Mar 16 | 42 | 0 | 23 | 0 |
| 31 Dec 15 | 39 | 1 | 21 | 0 |
| 30 Sep 15 | 37 | 1 | 20 | 0 |
| 30 Jun 15 | 34 | 1 | 19 | 0 |
| 31 Mar 15 | 34 | 1 | 18 | 0 |
| 31 Dec 14 | 35 | 1 | 18 | 0 |
| 30 Sep 14 | 32 | 1 | 17 | 0 |
| 30 Jun 14 | 30 | 0 | 16 | 0 |
| 31 Mar 14 | 26 | 0 | 15 | 0 |
| 31 Dec 13 | 22 | 0 | 14 | 0 |
| 30 Sep 13 | 20 | 0 | 13 | 0 |
| 30 Jun 13 | 18 | 1 | 12 | 0 |
Quality Earnings: SOM is currently unprofitable.
Growing Profit Margin: SOM is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SOM is unprofitable, and losses have increased over the past 5 years at a rate of 68.9% per year.
Accelerating Growth: Unable to compare SOM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SOM is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Return on Equity
High ROE: SOM has a negative Return on Equity (-35.15%), as it is currently unprofitable.